0093-9018 : Cyclosporine Modified 25 mg Oral Capsule, Liquid Filled


NDC0093-9018
Labeler: Teva Pharmaceuticals USA, Inc.
Product Type: Human Prescription Drug
Drug Name:  Cyclosporine Modified
Dosage Form: Oral Capsule, Liquid Filled
Application #: ANDA065110
Rev. Date: 


NDC Package Codes:

  • 0093-9018-65: 30 BLISTER PACK IN 1 CARTON (0093‑9018‑65) > 1 CAPSULE, LIQUID FILLED IN 1 BLISTER PACK (0093‑9018‑19)

Active Ingredients:

  • Cyclosporine

Dosage Strength:

  • 25 mg

Pharmaceutical Classes:

  • Calcineurin Inhibitor Immunosuppressant [EPC]
  • Calcineurin Inhibitors [MoA]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • P-Glycoprotein Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0093-9019 Cyclosporine Modified 50 mg Oral Capsule, Liquid Filled by Teva Pharmaceuticals USA, Inc.
  • 0093-9020 Cyclosporine Modified 100 mg Oral Capsule, Liquid Filled by Teva Pharmaceuticals USA, Inc.
  • 0093-5740 Cyclosporine 25 mg Oral Capsule, Liquid Filled by Teva Pharmaceuticals USA Inc
  • 0093-5741 Cyclosporine 50 mg Oral Capsule, Liquid Filled by Teva Pharmaceuticals USA Inc
  • 0093-5742 Cyclosporine 100 mg Oral Capsule, Liquid Filled by Teva Pharmaceuticals USA Inc

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0093-9018 QR Code

< Prev: 0093-8947Next: 0093-9019 >

Related Discussions:

cyclosporine capsule
My dog used to take Teva's 100 mg Cyclosporine. My pharmacy gave me a brand by Mayne pharma and now she is puking no...
cyclosporine 79mcgL is OK in human
I haved kidney transplant and my cyclosporine is a 79mc/L. is any concequense when is low of 100...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.